BioXcel Therapeutics (BTAI) Return on Assets (2018 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Return on Assets of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and down 14.41% quarter-over-quarter from 0.01% in Q4 2025.
BioXcel Therapeutics (BTAI) Return on Assets (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Return on Assets history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, up 3.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Assets was 0.01% in Q3 2022, with the low at 0.03% in Q3 2023.
- The 5-year median for Return on Assets is 0.02% (2024), against an average of 0.02%.
- The sharpest annual moves came in 2023 and 2024: Return on Assets declined 2 bps in 2023, then rose 2 bps in 2024.
- BioXcel Therapeutics' Return on Assets stood at 0.02% in 2022, then plunged by 56 bps to 0.03% in 2023, then soared by 34 bps to 0.02% in 2024, then grew by 22 bps to 0.01% in 2025, then decreased by 14 bps to 0.01% in 2026.
- Business Quant data shows BTAI's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.00% |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |